Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_assertion description "[Our findings suggest that deregulated AZGP1, PIP, S100A8 and UBE2C are critical for the aggressive breast cancer phenotype, which may be useful as novel therapeutic targets for drug development to complement established clinical variables.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_assertion evidence source_evidence_literature NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_assertion SIO_000772 24114735 NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_assertion wasDerivedFrom befree-2016 NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_assertion wasGeneratedBy ECO_0000203 NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1117967.RAjLQnmR89nrQxfxJpCw2wwNqCLf2EhOjncHo2KhtfByM130_provenance.